Funding gift for spinal injury clinical trial
A clinical trial to test the efficacy and safety of the transplantation of nasal cells to treat chronic spinal cord...
Search all articles within the Griffith Health topic
A clinical trial to test the efficacy and safety of the transplantation of nasal cells to treat chronic spinal cord...
World-first study determines the deadliest weapons made by Indigenous Australians.
Unlocking the secrets behind immune exhaustion in ME/CFS and Long COVID patients.
A Phase I human clinical trial is set to commence to test the efficacy and safety of the transplantation of olfactory cell nerve bridges to treat chronic spinal cord injury.
The second phase of a trial to implement a heat-detection system inside the homes of senior Australians will this time...
Salivary biomarkers could be the way forward in diagnosing liver fibrosis thanks to a partnership between Griffith University and Gallipoli...
Griffith University has named four winners at its prestigious Outstanding Alumni Awards 2024 ceremony in Brisbane with Leona Murphy taking out the top gong.
An ambitious program to help realise the United Nations’ Sustainable Development Goals (SDGs) has welcomed seven Griffith University students into...
Malnutrition continues to be a widespread issue in Australian aged care homes, but Griffith University researchers are striving to address...
A world-first trial to help improve the lives of Australians living with a debilitating spinal cord injury is a step closer with a $6.8 million Medical Research Future Fund grant.